Australia's Imricor Medical Systems jumps on clinical trial progress
04/11/2025 01:40
** Imricor Medical Systems IMR.AX jumps as much as 15% to A$1.57; marks biggest intraday pct jump since September 9 ** Stock hits highest since October 7; among top gainers on All Ordinaries index .AORD ** Medical devices maker announces successful completion of first ischemic ventricular tachycardia ablation ever performed under real-time MRI guidance in an iCMR lab ** Procedure meant to rectify hearth rythm disorder ** YTD, IMR gains 11.8% (Reporting by Shruti Agarwal in Bengaluru) ((Shruti.Agarwal@thomsonreuters.com))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion